title: Chronic anterior uveitis in common variable immunodeficiency.
abstract: OBJECTIVE
  To describe patients with uveitis and common variable immunodeficiency (CVID).
  
  
  METHODS
  Retrospective observational case series.
  
  
  METHODS
  Retrospective review of patients with uveitis and CVID, specifically focusing on clinical presentation and treatment.
  
  
  RESULTS
  Three patients with CVID and uveitis were identified. All patients had chronic anterior uveitis. Two required systemic immunosuppression to control uveitis, with one of these patients relapsing after discontinuation of immunoglobulin therapy. One improved on topical steroid therapy; however, follow-up on this patient did not extend beyond 4 months.
  
  
  CONCLUSIONS
  CVID can be associated with chronic anterior uveitis. Patients presenting with uveitis should be questioned about frequent infections and autoimmune disorders as part of the uveitis evaluation.
authors: Erica Z
authors: EZ
authors: Oltra
authors: Cody
authors: C
authors: Morris
authors: Andrea D
authors: AD
authors: Birnbaum
authors: Howard H
authors: HH
authors: Tessler
authors: Debra A
authors: DA
authors: Goldstein
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002648:Child; D002908:Chronic Disease; D017074:Common Variable Immunodeficiency / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005477:Fluprednisolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D000069285:Infliximab; D008875:Middle Aged; D012008:Recurrence; D016896:Treatment Outcome; D014606:Uveitis, Anterior / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D005477:Fluprednisolone; D000069285:Infliximab; C015808:difluprednate